<DOC>
	<DOCNO>NCT01600404</DOCNO>
	<brief_summary>Prospective evaluation cognitive function in-house patient suffer acute traumatic spinal cord injury three month initiation antimuscarinic treatment . The following hypothesis test : Antimuscarinic treatment result significantly worse cognitive test result three month traumatic spinal cord injury compare pre-treatment result result control group .</brief_summary>
	<brief_title>Effects Antimuscarinics Cognition Spinal Cord Injury</brief_title>
	<detailed_description>There two group : 1 ) patient receive antimuscarinic treatment 2 ) patient without antimuscarinic treatment ( control ) . The control group investigate order determine effect traumatic spinal cord injury cognition natural history potential cognitive impairment within first three month spinal cord injury . Six eight week traumatic spinal cord injury , patient examine order determine type neurogenic bladder dysfunction suffering . Patients suffer overactive bladder receive antimuscarinic treatment order prevent high urine storage voiding pressure , put kidney risk . Prior urologic examination , patient fulfil inclusion criterion contact . If informed consent give , cognitive function evaluate patient group use different standard neuropsychologic test . The neuropsychologic test repeat three month later . Evaluation take place standardize condition ( e.g . time day ) . Furthermore , different factor influence cognition , e.g . depression , pain , medication , assess begin end study .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>acute traumatic spinal cord injury primary rehabilitation / inhouse patient 1865 year age treatment group : indication antimuscarinic treatment ( oxybutynin , tolterodine willingness motivation participate study lesion level C4 traumatic brain injury ( initial Glasgow Coma Score &lt; 13 ) preexist dementia preexisting impaired cognitive function previous antimuscarinic treatment treatment group : antimuscarinic treatment oxybutynin , tolterodine acute psychologic disorder , disease , schizophrenia alcohol abuse , consumption illegal drug ( incl . marijuana ) moderate severe depression ( Beck Depression Inventory Score &gt; 18 ) moderate severe pain ( International Spinal Cord Injury Pain Basic Data Set ) progressive disease tricyclic antidepressant color blindness , impaired sight , blindness insufficient German language skill inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Muscarinic Antagonists</keyword>
	<keyword>Spinal Cord Injuries</keyword>
	<keyword>Urinary Bladder , Neurogenic</keyword>
	<keyword>Urinary Bladder , Overactive</keyword>
	<keyword>Overactive Detrusor</keyword>
</DOC>